Expression of prolactin receptor mRNA in oestrogen receptor positive breast cancers pre- and post-tamoxifen therapy
- 1 June 2004
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 30 (5) , 515-519
- https://doi.org/10.1016/j.ejso.2003.03.001
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Preoperative endocrine therapy for breast cancer.Endocrine-Related Cancer, 2000
- Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal WomenJNCI Journal of the National Cancer Institute, 1999
- Increased Expression of Prolactin Receptor Gene Assessed by Quantitative Polymerase Chain Reaction in Human Breast Tumors Versus Normal Breast TissuesJournal of Clinical Endocrinology & Metabolism, 1998
- Coexpression and Cross-Regulation of the Prolactin Receptor and Sex Steroid Hormone Receptors in Breast CancerJournal of Clinical Endocrinology & Metabolism, 1997
- Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytesEndocrinology, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Is tamoxifen also an anti-lactogen?Molecular and Cellular Endocrinology, 1991
- Tamoxifen Inhibition of Prolactin Action in the Mouse Mammary GlandEndocrinology, 1991
- Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.Journal of Clinical Oncology, 1984
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977